Ketamine has been advocated for use as an anaesthetic agent during diagnostic procedures in neurological patients by a number of writers (Corssen et al., 1969; Wilson, Fotias and Dillon, 1969) . Although its hypertensive action made some authors issue a caution on its use in patients with intracerebral vascular lesions (Brown, Cole and Murray, 1970) , none of these accounts mentioned the effects of ketamine on intracerebral pressure or blood flow. Evans and co-workers (1971) suggested that on occasion the administration of ketamine might be associated with undesirable levels of intrathecal pressure.
The present study was designed to compare the effects of a single intravenous injection of ketamine on the cerebrospinal fluid (cs.f.) pressure in patients with normal cs.f. pathways and in those with intracranial space-occupying lesions.
Because of the possibility of a rise in cs.f. pressure in the latter patients, it was felt that it would not be reasonable to perform the study except in anaesthetized patients when using controlled ventilation.
METHODS
Two groups of patients were studied. Group 1 comprised 11 patients who were to undergo lumbar discectomy and who were assumed to have normal cs.f. pathways. Group 2 comprised 9 patients with intracranial space-occupying lesions who were to undergo craniotomy. Informed consent was obtained for the investigation. Premedication comprised pethidine 50-100 mg and promethazine 12.5-25 mg, given intramuscularly 1 hour before anaesthetic induction which consisted of thiopentone in a dose of 200-350 mg, followed by alcuronium 10-20 mg. Prior to intubation, the lungs were ventilated with nitrous oxide (75%) and oxygen for 3 min. After intubation, ventilation was continued using a semiclosed circle system with carbon dioxide absorption. Ventilation was based on a minute volume of 80-100 ml/kg body weight at a rate of 10-15 cycles/min using a Bennett ventilator (BA-4). An intravenous infusion was commenced and a 20-gauge cannula (Medicut) was introduced into a radial artery in patients in whom the subsequent operative procedure warranted direct pressure monitoring. In the remaining cases, arterial pressure was measured with a sphygmomanometer. In the patients in whom direct pressure readings were made, these were recorded using a Statham pressure transducer (P23Dc) and a Grass Polygraph. With the patient in the lateral position a lumbar puncture was performed with a 21-gauge needle (above the level of the disc protrusion in Group 1 patients) and cs.f. pressure was recorded directly in the same way as the blood pressure. Care was taken to minimize cs.f. loss. The transducer was set on a level with the spine. These procedures occupied some 20-30 min from induction of anaesthesia. After recording the pressure for 2-6 min, and ensuring a free respiratory and cardiac pulsation, ketamine 1.0-1.3 mg/kg was injected as a single dose rapidly into the intravenous drip tubing. If there was little change in arterial or cs.f. pressure, readings were discontinued at a minimum of 6 min after the ketamine injection. When there was a response, observations were continued over a longer period. Soon after ketamine administration, an arterial blood sample was taken for blood-gas analysis. Digital compression over the puncture site was maintained for 10 min. No untoward sequelae were seen. At the conclusion of the observations the lumbar puncture needle was removed and the patient positioned for surgery. Mean c.s.f. pressures have been taken as the endexpiratory diastolic pressure +% c.s.f. pulse pressure. Mean systemic arterial pressure was similarly calculated as end-expiratory diastolic pressure + •$• of the difference between systolic and diastolic pressures. After c.s.f. pressure, in mm H 2 O had been converted to mm Hg, mean cerebral perfusion pressure was obtained by subtracting c.s.f. pressure from mean arterial pressure.
RESULTS
C.s.f. pressure. In the Group 1 (lumbar discectomy) patients, there was no consistent trend toward any change in c.s.f. pressure although rises did occur in individual cases. The results are shown in tables I, II and figure 1. Comparing the pressure at the time of administration of ketamine with the maximum pressure recorded after this in each case, the mean maximum pressure rise was 14 + 6 (SE) mm H,O. This and subsequent similar calculations, compared the initial pressure with the maximum attained thereafter irrespective of the time at which it occurred. This change was not significant when subjected to a paired Student West. In the Group 2 (intracranial lesion) patients, the c.s.f. pressure rose to a substantial degree in 6 of the 9 patients. The mean maYimnm pressure rise was 150 + 61 (SE) mm H,O. This change was statistically significant at the 5% level of probability using a paired Student ttest. In one case two records were taken from the same patient, a boy of 11 with a tumour in the region of the third ventricle. On the first occasion when ketamine induced a marked rise in c.s.f. pressure (from 170 to 600 mm H 2 O after 10 min), a Holter valve was inserted to establish c.s.f. drainage to the right atrium. Prior to craniotomy 2 weeks later, ketamine did not produce any changes in the intrathecal pressures (pressures ranged from 220 to 200 mm H 2 O). Of the other two cases in this group whose c.s.f. pressure did not change, one was a young man with a small frontal glioma, and the other a man with a simple parietal subarachnoid cyst.
Arterial pressure (tables I, II; fig. 1 ). Although the mean changes were relatively small, there was an increase in arterial pressure following ketamine. In the Group 1 patients the maximum mean rise was 7 + 3 (SE) mm Hg and in the Group 2 patients, 24 +10 (SE) mm Hg. Using a paired Student f-test the changes were significant at between 2 and 5% and at 1% levels of probability respectively.
Cerebral perfusion pressures (table III) . These were calculated, as described earlier, in the intracerebral lesion patients. Comparing mean pressures at the time of ketamine administration with the mean pressures at time of maximum c.s.f. pressure, there was a change in mean cerebral perfusion pres- fig. 1 ). There was a slight rise in pulse rate in both groups. The change in mean values was approximately 10 beats/min.
Ventilation. As determined by the blood-gas measurements (table I) carried out after ketamine administration, the Group 1 patients had Pa C02 values ranging from 25 to 45 mm Hg with a mean value of 37 + 2 (SE) mm Hg. In Group 2, the range was 32-47 mm Hg with a mean value of 38 + 2 (SE) mm Hg.
Side effects. There were no anaesthetic or surgical sequelae which could be related to the use of ketamine. All patients were specifically questioned, with regard to dreams or hallucinations, on the day following surgery. No positive reports were obtained.
DISCUSSION
Since the suggestion by Evans and associates (1971) that ketamine administration might be associated with a rise in c.s.f. pressure, some confirmatory reports have appeared. Gardner, Olsen and Lichtiger (1971) examined several patients prior to spinal anaesthesia and found that intravenous injection of ketamine produced rises in both mean blood pressure and c.s.f. pressure. Whyte and associates (1972) studied the effects of ketamine in two patients, one with and one without raised intra- cranial pressure. They were able to demonstrate a marked rise in intraventricular pressure following intravenous injection of ketamine in the patient with raised intracranial pressure. They also noted reduction of this response with thiopentone, and comment that the short duration of this modification is related to the time taken for distribution of the thiopentone. Dawson, Michenfelder and Theye (1971) studied the effects of ketamine on c.s.f. pressure and cerebral blood flow in dogs and the manner in which the observed rises in both were prevented by thiopentone given immediately before the ketamine. Because of the time between the injection of thiopentone for induction of anaesthesia and the administration of ketamine in the present study, it is unlikely that thiopentone greatly altered the pattern of the c.si. pressure changes.
The magnitude of the changes in both c.si. and arterial pressures in the present study were less than those reported by Gardner, Olsen and Lichtiger (1971) . The mean dose of ketamine in the present study was less than in either of the reports mentioned earlier (1.1 mg/kg as opposed to 2 mg/kg). In addition, it is probable that the response was reduced by general anaesthesia. Bovill and associates (1971) found that the effect of ketamine on arterial pressure was greater when the drug was used as a sole agent than when it was used in combination with nitrous oxide. The rise in c.s.f. pressure associated with ketamine was minimal in the "normal" anaesthetized subjects but considerably greater in those patients with altered c.s.f. flow pathways as a consequence of an intracerebral lesion. The modification of the response to ketamine by establishment of c.s.f. drainage through a Holter valve strongly supports this finding. As the mean values for Pa 002 were similar (and near normal) in both groups of patients, it is unlikely that ventilation played a part in the different c.s.f. pressure responses in the two groups. It is also noteworthy that the rise in arterial pressure associated with ketamine was greater in the patients with space-occupying lesions.
The reflection of intracerebral pressure changes in the subarachnoid space suggests that there is a rise in brain volume, presumably as a result of increased cerebral blood flow. Dawson, Michenfelder and Theye (1971) have demonstrated that this is so in studies in dogs and suggest that ketamine may produce this effect by acting as a cerebral metabolic stimulant and vasodilator. Takeshita, Okuda and Sari (1972) suggest that ketamine increases cerebral blood flow but does not significantly alter cerebral metabolism in normal man. They also recorded an increase in cerebral perfusion pressure. By contrast, halothane causes a fall in arterial pressure and a rise in cerebral blood flow in normocapnic subjects (Freeman, 1969) by a process of cerebral vasodilatation. In parallel with the present study, Jennett and associates (1969) showed that the effect of inhalational anaesthetic agents in raising c.s.f. pressure was more marked in patients with intracranial space-occupying lesions. However, comparing the effects of halothane and of ketamine on c.s.f. pressure, it is seen that while they are similar in this respect, halothane tends to cause a fall in systemic blood pressure, while ketamine causes a rise. In the present study this blood pressure rise has a similar time course to the c.s.f. pressure rise in patients with intracranial lesions. Calculation of the changes in cerebral perfusion pressure by the method of Fitch and associates (1969) suggests that in general this is maintained, although falls did occur in the patients who showed the greatest rise in c.s.f. pressure after ketamine administration.
There do not appear to be any published studies which show whether the rise in arterial pressure would, to any degree, protect areas of marginally ischaemic brain against the adverse effects of a further rise in intracerebral pressure. In addition, the effect of ketamine on c.s.f. pressure and cerebral blood flow in the presence of different levels of arterial carbon dioxide has not been clearly established.
In the light of current knowledge and of the changes in c.s.f. pressure demonstrated in this and other studies, it is suggested that intravenous injection of ketamine should be used with caution in patients who are known to have an intracerebral space-occupying lesion or raised intracranial pressure.
EFFET 
RESUMEN
El efecto de una inyeccion intravenosa de 1,1 mg/kg de cetamina sobre la presion del liquido cefalorraquideo (c.s.f.) fue estudiado en veinte pacientes durante la anestesia por oxido nitroso-oxigeno y relajante. En once pacientes con yias normales para el c.s.f. no hubo alteraci6n significativa de la presion, pero en seis pacientes de nueve con lesiones ocupadoras de espacio intracraneal hubo una eleyacion sustancial de la presi6n del c.s.f. Estos resultados sugieren que la cetamina debe ser utilizada con cuidado en pacientes con lesiones ocupadoras de espacio intracraneal. 
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